Rear tail self-destruction type insulin syringe
By designing a rear tail self-destructive insulin syringe, using push rods, wing plates, limit chambers and other structures, the existing syringe has been solved with complex structure and cumbersome operation, and the syringe has been safely self-destructed and effectively prevented from reuse, ensuring that The safety of the syringe and the effective use of the medicine solution.
Patent Information
- Application Number
- CN202420368454.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-28
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2034-02-28
AI Technical Summary
The existing insulin syringes with self-destructive functions are complex in structure and cumbersome in operation, which leads to obstacles during use and is difficult to effectively prevent damage caused by repeated use and incorrect operation of the syringe.
A rear tail self-destructive insulin syringe is designed, including push rods, syringes with wings, limit chambers, anti-fall steps, support rings, protective covers and blocks. Through these structures, the self-destruction of the syringe and Prevent reuse.
It realizes simplified operation to prevent repeated use and incorrect operation of the syringe from being damaged, ensuring the safety of the syringe when not in use and the effective use of the drug solution.
Smart Images

Figure CN222018735U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to a rear-end self-destructive insulin syringe. Background Art
[0002] There are various tools for insulin injection, and the most commonly used one is the disposable insulin syringe. Its purpose is to prevent bad people from using the syringe multiple times, causing infection and other problems at the patient's injection site.
[0003] Currently, the insulin syringes with self-destruction function on the market have relatively complex structures, and the self-destruction steps are cumbersome. They need to be operated with both hands, which will cause certain obstacles when used. Summary of the invention
[0004] The utility model aims to design a rear-end self-destructive insulin syringe.
[0005] The utility model includes a push rod and a syringe with a wing plate, a limiting cavity connected to the opening of the syringe is arranged at the rear end of the syringe, the inner diameter of the limiting cavity is larger than the inner diameter of the syringe, a push rod hole is arranged at the rear end of the limiting cavity, the inner diameter of the push rod hole is smaller than the inner diameter of the limiting cavity, an anti-falling step is arranged on the push rod, the maximum radial dimension of the anti-falling step is larger than the inner diameter of the push rod hole and smaller than or equal to the inner diameter of the limiting cavity, an extrusion groove connecting the front and rear surfaces of the anti-falling step is arranged around the anti-falling step; the length from the front end surface of the anti-falling step to the front end of the push rod is larger than or equal to the length of the inner cavity of the syringe, and the length from the rear end surface of the anti-falling step to the front end of the push rod is smaller than or equal to the length from the rear end of the limiting cavity to the front end of the inner cavity of the syringe.
[0006] Furthermore, a protruding support ring is provided at the rear of the inner cavity of the syringe, and the inner diameter of the support ring is adapted to the outer diameter of the push rod.
[0007] Furthermore, the front surface of the anti-falling step and the inner surface of the push rod hole at the rear end of the limiting cavity are tapered.
[0008] Furthermore, the inner cavity of the limiting cavity and the inner cavity of the syringe are connected through a conical surface.
[0009] Furthermore, a protective cover with a rear end face is arranged outside the limiting cavity and cooperates with its outer wall. The front end of the protective cover can cooperate with the rear end face of the wing plate. The axial length of the protective cover is greater than the sum of the axial length of the limiting cavity and the length from the rear surface of the push plate to the front surface of the anti-fall step.
[0010] Furthermore, a protruding clamping block is arranged on the outer wall of the limiting cavity, and at least two clamping rings are arranged on the inner surface of the protective cover along its axial direction.
[0011] The utility model can prevent the syringe from being reused, and after adding the corresponding structure, further designs a corresponding structure to prevent the unused syringe from being damaged due to misoperation, thereby making the structure more perfect. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 This is a three-dimensional diagram of an embodiment of the utility model when the push rod is not pushed to the front end, wherein the protective cover is not shown;
[0013] Figure 2 is a three-dimensional diagram of the shield;
[0014] Figure 3 is a cross-sectional view of 1;
[0015] Figure 4 is a cross-sectional view of the shield;
[0016] Figure 5 It is a cross-sectional view of the push rod of this embodiment when it is pushed to the front end;
[0017] Figure 6 for Figure 4 A magnified view of point A;
[0018] Among them, 1. syringe, 2. wing plate, 3. limit cavity, 4. block, 5. push rod, 6. anti-fall step, 7. push plate, 8. extrusion groove, 9. clamping ring, 10. protective cover, 11. push rod hole, 12. support ring, L1, axial length of the limit cavity, L2, length from the rear surface of the push plate to the front surface of the anti-fall step. DETAILED DESCRIPTION
[0019] As shown in the figure, this embodiment includes a syringe 1 and a push rod 5 matched therewith. The outer surface of the syringe 1 is provided with a wing plate 2, and the rear end of the push rod 5 is provided with a push plate 7.
[0020] A limiting cavity 3 is formed or made integrally with the syringe 1 at the rear end thereof, the inner diameter of the limiting cavity 3 is larger than the inner diameter of the syringe 1, and the inner surface of the connection between the two is a conical surface. The rear end surface of the limiting cavity 3 is provided with a push rod hole 11, the rear part of the inner surface of the push rod hole 11 is a conical surface, and the push rod 5 passes through the push rod hole 11 and the limiting cavity 3 to enter the syringe 1.
[0021] In this embodiment, a protruding anti-falling step 6 is provided at the rear of the push rod 5. The circumference of the anti-falling step 6 may be irregularly shaped, but is generally circular, but the radial dimension of the largest part thereof is greater than the inner diameter of the push rod hole 11 and less than or equal to the inner diameter of the limiting cavity 3. An extrusion groove 8 is provided around the anti-falling step 6 to connect its front and rear surfaces, and the bottom position of the extrusion groove 8 corresponds to the outer diameter position of the push rod 5. The circumference of the anti-falling step 6 is a conical surface or an arc surface that is smaller in the front and larger in the back. The length from the front end surface of the anti-falling step 6 to the front end of the push rod 5 is greater than or equal to the length of the inner cavity of the syringe 1, and the length from the rear end surface of the anti-falling step 6 to the front end of the push rod 5 is less than or equal to the length from the back of the limiting cavity 3 to the front end of the inner cavity of the syringe 1.
[0022] A protruding support ring 12 is provided near the rear end of the inner cavity of the syringe 1 to support and guide the push rod 5.
[0023] A group of protruding blocks 4 are arranged on the outer surface of the limiting cavity 3 along its circumference, and a protective cover 10 is installed outside the limiting cavity 3. The front end surface of the protective cover 10 can cooperate with the rear end surface of the wing plate 2, and three groups of snap rings 9 are arranged on the inner surface along its axial direction, and at least one snap ring 9 can cooperate with the block 4 to position the protective cover 10 outside the limiting cavity 3. The axial length of the protective cover 10 is greater than the sum of L1 and L2.
[0024] In this embodiment, when not in use and before injection, the anti-falling step 6 is located outside the limiting cavity 3. When the injection is nearly completed, the anti-falling step 6 can enter the limiting cavity 3 by further pushing the push plate 7. Since the front surface of the anti-falling step 6 and part of the surface of the limiting cavity 3 are conical surfaces, and the anti-falling step 6 is provided with an extrusion groove 8, the anti-falling step 6 can enter the limiting cavity 3. Under the joint action of the rear end surface of the limiting cavity 3 and the anti-falling step 6, the push rod 5 cannot retreat, thereby preventing the embodiment from being reused.
[0025] Due to the existence of the limiting cavity 3, the length of the syringe 1 is actually extended. Therefore, a support ring 12 is provided in the rear inner cavity of the syringe 1 to support and guide the push rod 5, so that the syringe is more stable when in use.
[0026] The limiting cavity 3 is connected to the syringe 1 via a conical surface, which can prevent the drug solution from remaining therein, and under certain circumstances, the anti-falling step 6 can cooperate with the conical surface, so that the push rod 6 can reach the front end of the syringe 1 as much as possible, reducing the waste of drug solution.
[0027] In the sealed state before use, the protective cover 10 is installed outside the position limiting cavity 3. Since the relative dimensions of the protective cover 10 and other parts are designed, the anti-falling step 6 can be kept outside the position limiting cavity 3 in this case, and the anti-falling step 6 can be prevented from entering the position limiting cavity 3 due to accidental contact of the push plate 7 by external force, thereby making the present embodiment unusable.
[0028] From the above description, it can be known that this embodiment can prevent the syringe from being reused and effectively prevent the unused syringe from being damaged due to misoperation.
Claims
1. A rear-end self-destructive insulin syringe, comprising a push rod and a syringe with a wing plate, characterized in that: A limiting cavity connected to its opening is provided at the rear end of the syringe, and the inner diameter of the limiting cavity is larger than the inner diameter of the syringe, and a push rod hole is provided at the rear end of the limiting cavity, and the inner diameter of the push rod hole is smaller than the inner diameter of the limiting cavity, and an anti-falling step is provided on the push rod, and the maximum radial dimension of the anti-falling step is larger than the inner diameter of the push rod hole and smaller than or equal to the inner diameter of the limiting cavity, and an extrusion groove connecting the front and rear surfaces of the anti-falling step is provided around the anti-falling step; the length from the front end surface of the anti-falling step to the front end of the push rod is greater than or equal to the length of the inner cavity of the syringe, and the length from the rear end surface of the anti-falling step to the front end of the push rod is less than or equal to the length from the rear end of the limiting cavity to the front end of the inner cavity of the syringe.
2. The tail self-destructing insulin syringe according to claim 1 is characterized in that: A protruding support ring is arranged at the rear of the inner cavity of the syringe, and the inner diameter of the support ring is adapted to the outer diameter of the push rod.
3. The tail self-destructive insulin syringe according to claim 1 or 2, characterized in that: The front surface of the anti-falling step and the inner surface of the push rod hole at the rear end of the limiting cavity are at least in the rear part thereof are conical surfaces.
4. The tail self-destructive insulin syringe according to claim 1 or 2, characterized in that: The inner cavity of the limiting cavity is connected with the inner cavity of the syringe through a conical surface.
5. The tail self-destructive insulin syringe according to claim 1 or 2, characterized in that: A protective cover with a rear end face is arranged outside the limiting cavity to cooperate with its outer wall. The front end of the protective cover can cooperate with the rear end face of the wing plate. The axial length of the protective cover is greater than the sum of the axial length of the limiting cavity and the length from the rear surface of the push plate to the front surface of the anti-falling step.
6. The tail self-destructing insulin syringe according to claim 5 is characterized in that: The outer wall of the limiting cavity is provided with a protruding clamping block, and the inner surface of the protective cover is provided with at least two clamping rings along the axial direction thereof.
